PubMed:8621667 / 338-487 JSONTXT

{"project":"sentences","denotations":[{"id":"T4","span":{"begin":0,"end":149},"obj":"Sentence"},{"id":"T4","span":{"begin":0,"end":149},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Heterozygous individuals (Y248C) had a 40% decrease in plasma angiotensinogen concentration and a 35% reduction of the angiotensin I production rate."}

{"project":"Anatomy-UBERON","denotations":[{"id":"T1","span":{"begin":55,"end":61},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0001969"}],"text":"Heterozygous individuals (Y248C) had a 40% decrease in plasma angiotensinogen concentration and a 35% reduction of the angiotensin I production rate."}